Trends in hospital admissions and mortality from asthma and chronic obstructive pulmonary disease in Australia, 1993-2003

Medical Journal of Australia

Volumn 186, Issue 8, 2007, Pages 408-411

  Wilson, David Hugh ^a,b   Tucker, Graeme ^c   Frith, Peter ^d   Appleton, Sarah ^a   Ruffin, Richard E ^a,b   Adams, Robert J ^a,b  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c Department of Health ^*  (Australia)

^d REPATRIATION GENERAL HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ARTIFICIAL VENTILATION; ASTHMA; AUSTRALIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE SEVERITY; DRUG USE; FEMALE; GENDER BIAS; HEALTH CARE POLICY; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MORBIDITY; MORTALITY; PRIMARY PREVENTION; PULMONARY REHABILITATION; RETROSPECTIVE STUDY; SECONDARY PREVENTION;

EID: 34247897231     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2007.tb00974.x     Document Type: Article

References (30)

1. Woolcock AJ, Bastiampillai SA, Marks GB, Keena VA. The burden of asthma in Australia. Med J Aust 2001; 175: 141-145.
2. Wilson DH, Adams RJ, Tucker G, et al. Trends in asthma prevalence and population changes in South Australia, 1990-2003. Med J Aust 2006; 184: 226-229.
3. Manton KG. The global impact of non-communicable diseases: estimates and projections. World Health Stat Q 1988; 41: 255-266.
4. Mannino DM. COPD: epidemiology, prevalence, morbidity and mortality and disease heterogeneity. Chest 2002; 121 (5 Suppl): 121S-126S.
5. Australian Institute of Health and Welfare. Chronic respiratory diseases in Australia. Canberra: AIHW, 2005. (AIHW Cat. No. PHE 63.)
6. Berend N. Epidemiological survey of chronic obstructive pulmonary disease and alpha-1-antitrypsin deficiency in Australia. Respirology 2001; 6 Suppl: S21-S25.
7. Fardy HJ. Moving towards organised care of chronic disease. The 3+ visit plan. Aust Fam Physician 2001; 30: 121-125.
8. Minkoff NB. Analysis of the current care model of the COPD patient: a health outcomes assessment and economic evaluation. J Manag Care Pharm 2005; 11 (6 Suppl A): S3-S7.
9. Australian Institute of Health and Welfare. Interactive national hospital morbidity data. Principal diagnosis data cubes. http://www.aihw.gov.au/hospitals/datacubes/datacube_06-pdx.cfm (accessed Jan 2006).
10. Mathers C, Vos T, Stevenson C. The burden of disease and injury in Australia. Canberra: Australian Institute of Health and Welfare, 1999. (AIHW Cat. No. PHE 17.) http://www.aihw.gov.au/publications/index.cfm/ title/5180 (accessed Feb 2007).
11. Population health in South Australia: burden of disease and injury estimates, 1991 to 2001. Adelaide: Government of South Australia, 2005.
12. Halbert RJ, Natoli JL, Gano A, et al. Global burden of COPD: systematic review and meta-analysis. Eur Respir J 2006; 28: 523-532.
13. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. 2006 update. http://gold-copd.com/Guidelineitem. asp?l1=2&l2=1&intld=996 (accessed Mar 2007).
14. Mannino DM, Homa DM, Akinbami LJ, et al. Chronic obstructive pulmonary disease surveillance - United States, 1971-2000. MMWR Surveill Summ 2002; 51(6): 1-16.
15. Wilson D, Adams R, Appleton S, Ruffin R. Difficulties identifying and targeting COPD and population-attributable risk of smoking for COPD: a population study. Chest 2005; 128: 2035-2042.
16. Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ 1977; 1: 1645-1648.
17. Coultas DB, Mapel D, Gagnon R, Lydick E. The health impact of undiagnosed airflow obstruction in a national sample of United States adults. Am J Respir Crit Care Med 2001; 164: 372-377.
18. O'Donnell DE, Voduc N, Fitzpatrick M, Webb KA. Effect of salmeterol on ventilatory response to exercise in chronic obstructive pulmonary disease. Eur Respir J 2004; 24: 86-94.
19. Maltais F, Hamilton A, Marciniuk D, et al. Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD. Chest 2005; 128: 1168-1178.
20. Sin DD, McAlister FA, Man SF, Anthonisen NR. Contemporary management of chronic obstructive pulmonary disease: scientific review. JAMA 2003; 290: 2301-2312.
21. Calverly PM, Anderson JA, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007; 356: 775-789.
22. Salman GF, Mosier MC, Beasley BW, Calkins DR. Rehabilitation for patients with chronic obstructive pulmonary disease: meta-analysis of randomized controlled trials. J Gen Intern Med 2003; 18: 213-221.
23. Marks GB, Poulos LM. A nationwide perspective on asthma in older Australians. Med J Aust 2005; 183 (1 Suppl): S14-S16.
24. Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P, et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005; 60: 925-931.
25. Australian Centre for Asthma Monitoring. Asthma in Australia. Asthma Series Number 2. Canberra: Australian Institute of Health and Welfare, 2005.
26. White V, Hill D, Siahpush M, Bobevski I. How has the prevalence of cigarette smoking changed among Australian adults? Trends in smoking prevalence between 1980 and 2001. Tob Control 2003; 12 Suppl 2: ii67-ii74.
27. Australian Institute of Health and Welfare. 2004 National Drug Strategy Household Survey. Canberra: AIHW, 2005. (AIHW Cat. No. PHE 57.)
28. Chapman KR. Chronic obstructive pulmonary disease: are women more susceptible than men? Clin Chest Med 2004; 25: 331-341.
29. Tinkelman DG, Price DB, Nordyke RJ, et al. Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over. J Asthma 2006; 43: 75-80.
30. Fabbri L, Caramori G, Beghe B, et al. Chronic obstructive pulmonary disease international guidelines. Curr Opin Pulm Med 1998; 4: 76-84.